Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The purpose of this study is to evaluate the efficacy and safety of multiple doses of tanezumab administered every 8 weeks in treating chronic low back pain. Tanezumab is a monoclonal antibody directed against human nerve growth factor.
Inclusion criteria
- low back pain